222 related articles for article (PubMed ID: 26162980)
1. Drug-in-cyclodextrin-in-liposomes: A novel drug delivery system for flurbiprofen.
Zhang L; Zhang Q; Wang X; Zhang W; Lin C; Chen F; Yang X; Pan W
Int J Pharm; 2015 Aug; 492(1-2):40-5. PubMed ID: 26162980
[TBL] [Abstract][Full Text] [Related]
2. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
[TBL] [Abstract][Full Text] [Related]
3. Enhanced bioavailability of orally administered flurbiprofen by combined use of hydroxypropyl-cyclodextrin and poly(alkyl-cyanoacrylate) nanoparticles.
Zhao X; Li W; Luo Q; Zhang X
Eur J Drug Metab Pharmacokinet; 2014 Mar; 39(1):61-7. PubMed ID: 23700219
[TBL] [Abstract][Full Text] [Related]
4. Preparation and Characterization of Liposomes Double-loaded with Amphotericin B and Amphotericin B/hydroxypropyl-beta-cyclodextrin Inclusion Complex.
Tran THY; Vu TTG; Pham TMH
Pharm Nanotechnol; 2021; 9(3):236-244. PubMed ID: 33745428
[TBL] [Abstract][Full Text] [Related]
5. A novel osmotic pump-based controlled delivery system consisting of pH-modulated solid dispersion for poorly soluble drug flurbiprofen: in vitro and in vivo evaluation.
Li S; Wang X; Wang Y; Zhao Q; Zhang L; Yang X; Liu D; Pan W
Drug Dev Ind Pharm; 2015; 41(12):2089-99. PubMed ID: 26304493
[TBL] [Abstract][Full Text] [Related]
6. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.
Shinde UA; Joshi PN; Jain DD; Singh K
Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402
[TBL] [Abstract][Full Text] [Related]
7. Flurbiprofen-loaded niosomes-in-gel system improves the ocular bioavailability of flurbiprofen in the aqueous humor.
El-Sayed MM; Hussein AK; Sarhan HA; Mansour HF
Drug Dev Ind Pharm; 2017 Jun; 43(6):902-910. PubMed ID: 27977311
[TBL] [Abstract][Full Text] [Related]
8. Amisulpride-CD-Loaded Liposomes: Optimization and In Vivo Evaluation.
Shukr MH; Ahmed Farid OA
AAPS PharmSciTech; 2018 Aug; 19(6):2658-2671. PubMed ID: 29943282
[TBL] [Abstract][Full Text] [Related]
9. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.
Han F; Yin R; Che X; Yuan J; Cui Y; Yin H; Li S
Int J Pharm; 2012 Dec; 439(1-2):349-57. PubMed ID: 22989987
[TBL] [Abstract][Full Text] [Related]
10. Delivery of fluorescent-labeled cyclodextrin by liposomes: role of transferrin modification and phosphatidylcholine composition.
Chen J; Yao J; Ma Z; Peng P; Lu S; Hu Y; Xu F; Yang Y; Yang X
J Liposome Res; 2017 Mar; 27(1):21-31. PubMed ID: 26911560
[TBL] [Abstract][Full Text] [Related]
11. A comparison between conventional liposome and drug-cyclodextrin complex in liposome system.
Wang WX; Feng SS; Zheng CH
Int J Pharm; 2016 Nov; 513(1-2):387-392. PubMed ID: 27640244
[TBL] [Abstract][Full Text] [Related]
12. Sustained release of intravitreal flurbiprofen from a novel drug-in-liposome-in-hydrogel formulation.
Pachis K; Blazaki S; Tzatzarakis M; Klepetsanis P; Naoumidi E; Tsilimbaris M; Antimisiaris SG
Eur J Pharm Sci; 2017 Nov; 109():324-333. PubMed ID: 28843864
[TBL] [Abstract][Full Text] [Related]
13. Development of novel flurbiprofen-loaded solid self-microemulsifying drug delivery system using gelatin as solid carrier.
Kim DW; Kang JH; Oh DH; Yong CS; Choi HG
J Microencapsul; 2012; 29(4):323-30. PubMed ID: 22233141
[TBL] [Abstract][Full Text] [Related]
14. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery.
Kawadkar J; Pathak A; Kishore R; Chauhan MK
Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934
[TBL] [Abstract][Full Text] [Related]
15. Ternary complexes of flurbiprofen with HP-beta-CD and ethanolamines characterization and transdermal delivery.
Maitre MM; Longhi MR; Granero GG
Drug Dev Ind Pharm; 2007 Mar; 33(3):311-26. PubMed ID: 17454064
[TBL] [Abstract][Full Text] [Related]
16. Enhanced oral bioavailability of flurbiprofen by combined use of micelle solution and inclusion compound.
Li DX; Han MJ; Balakrishnan P; Yan YD; Oh DH; Joe JH; Seo Y; Kim JO; Park SM; Yong CS; Choi HG
Arch Pharm Res; 2010 Jan; 33(1):95-101. PubMed ID: 20191350
[TBL] [Abstract][Full Text] [Related]
17. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
[TBL] [Abstract][Full Text] [Related]
18. Enhanced solubility and bioavailability of flurbiprofen by cycloamylose.
Baek HH; Kwon SY; Rho SJ; Lee WS; Yang HJ; Hah JM; Choi HG; Kim YR; Yong CS
Arch Pharm Res; 2011 Mar; 34(3):391-7. PubMed ID: 21547670
[TBL] [Abstract][Full Text] [Related]
19. The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system.
Chen H; Pan H; Li P; Wang H; Wang X; Pan W; Yuan Y
Colloids Surf B Biointerfaces; 2016 Jul; 143():455-462. PubMed ID: 27037783
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of dissolution and bioavailability of flurbiprofen by low molecular weight chitosans.
Anraku M; Arahira M; Mady FM; Khaled KA; Yamasaki K; Seo H; Imai T; Otagiri M
Pharmazie; 2010 Jul; 65(7):461-6. PubMed ID: 20662311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
